These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11023073)

  • 1. Factors associated with TT (tetanus toxoid) immunization among pregnant women, in Saparua, Maluku, Indonesia.
    Roosihermiatie B; Nishiyama M; Nakae K
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):91-5. PubMed ID: 11023073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetanus toxoid immunization coverage among women in zone 3 of Dhaka city: the challenge of reaching all women of reproductive age in urban Bangladesh.
    Perry H; Weierbach R; Hossain I; Islam R
    Bull World Health Organ; 1998; 76(5):449-57. PubMed ID: 9868835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with missed opportunities to immunise with tetanus toxoid at a tertiary health institution in Nigeria.
    Edet EE; Ikpeme BM; Ndifon WO; Oyo-Ita AE
    Cent Afr J Med; 1998 Aug; 44(8):199-202. PubMed ID: 10101419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice and knowledge regarding prevention of tetanus among nursing personnel in Delhi.
    Kumar R; Taneja DK; Dabas P; Ingle GK
    Indian J Public Health; 2007; 51(1):73-4. PubMed ID: 18232153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological factors associated with neonatal tetanus mortality: observations from a cluster survey in Nigeria.
    Eregie CO
    East Afr Med J; 1993 Jul; 70(7):434-7. PubMed ID: 8293702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus.
    Dietz V; Milstien JB; van Loon F; Cochi S; Bennett J
    Bull World Health Organ; 1996; 74(6):619-28. PubMed ID: 9060223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of tetanus toxoid for the prevention of neonatal tetanus. 1. Reduction of neonatal mortality by immunization of non-pregnant and pregnant women in rural Bangladesh.
    Rahman M; Chen LC; Chakraborty J; Yunus M; Chowdhury AI; Sarder AM; Bhatia S; Curlin GT
    Bull World Health Organ; 1982; 60(2):261-7. PubMed ID: 6980736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missed opportunities for tetanus vaccination in pregnant women, and factors associated with seropositivity.
    Kalaça S; Yalçin M; Simşek Yavuz S
    Public Health; 2004 Jul; 118(5):377-82. PubMed ID: 15178146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems.
    Dietz V; Galazka A; van Loon F; Cochi S
    Bull World Health Organ; 1997; 75(1):81-93. PubMed ID: 9141753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus.
    Deming MS; Roungou JB; Kristiansen M; Heron I; Yango A; Guenengafo A; Ndamobissi R
    Bull World Health Organ; 2002; 80(9):696-703. PubMed ID: 12378286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a tetanus toxoid immunization mass campaign on neonatal tetanus mortality in Aceh Province, Indonesia.
    Yusuf B; Solter S; Bertsch D; Arnold RB
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):351-6. PubMed ID: 1818385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal tetanus elimination in Pakistan: progress and challenges.
    Lambo JA; Nagulesapillai T
    Int J Infect Dis; 2012 Dec; 16(12):e833-42. PubMed ID: 22940280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage and factors associated with tetanus toxoid vaccination status among females of reproductive age in Peshawar.
    Afridi NK; Hatcher J; Mahmud S; Nanan D
    J Coll Physicians Surg Pak; 2005 Jul; 15(7):391-5. PubMed ID: 16197865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of universal immunization programme on the incidence of tetanus neonatorum.
    Joshi PL; Bhattacharya M; Arya RC; Raj B; Walia D
    Indian Pediatr; 1992 Jun; 29(6):773-5. PubMed ID: 1500143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetanus immunity among pregnant women attending antenatal care in Dar es Salaam, Tanzania.
    Aboud S; Lyamuya EF; Kristoffersen EK; Matre R
    Afr J Reprod Health; 2002 Aug; 6(2):87-93. PubMed ID: 12476720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone.
    Yaya S; Kota K; Buh A; Bishwajit G
    BMC Public Health; 2020 Jun; 20(1):855. PubMed ID: 32503478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaling up interventions to eliminate neonatal tetanus: factors associated with the coverage of tetanus toxoid and clean deliveries among women in Vientiane, Lao PDR.
    Masuno K; Xaysomphoo D; Phengsavanh A; Douangmala S; Kuroiwa C
    Vaccine; 2009 Jul; 27(32):4284-8. PubMed ID: 19450637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of tetanus toxoid for the prevention of neonatal tetanus. 2. Immunization acceptance among pregnant women in rural Bangladesh.
    Rahman M; Chen LC; Chakraborty J; Yunus M; Faruque AS; Chowdhury AI
    Bull World Health Organ; 1982; 60(2):269-77. PubMed ID: 6980737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge regarding tetanus toxoid immunization among persons attending health mela in Delhi.
    Taneja DK; Kumar R; Dabas P; Ingle GK
    J Commun Dis; 2003 Dec; 35(4):256-62. PubMed ID: 15909753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer rate of transplacental immunity to tetanus from non-immunized and immunized mothers.
    Sangpetchsong V; Vichaikummart S; Vichitnant A; Podhipak A
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):275-80. PubMed ID: 6523168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.